BioXcel Therapeutics, Inc. (BTAIQ) stock
BTAIQOTCPharmaceutical PreparationsFiscal year ends December 31
$0.03−0.00 (-13.49%)
Close on Oct 19, 2026Market cap $757.50KP/E –Yield –
BioXcel Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BioXcel Therapeutics's price to book ratio was 20.0× on Oct 31, 2023, against 2.1× a year earlier. Over the last 5 years it ranged from 1.3× to 25.2×, with a median of 4.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Oct 31, 2023 | 20.0× | +15.3 |
| 2022 | Dec 30, 2022 | 4.7× | +2.4 |
| 2021 | Dec 31, 2021 | 2.3× | −2.8 |
| 2020 | Dec 31, 2020 | 5.1× | −2.6 |
| 2019 | Dec 31, 2019 | 7.7× | +6.3 |
| 2018 | Dec 31, 2018 | 1.3× | – |
See a number that looks wrong?